PEPITA JEAN: Open Payments
NPI 1205269925 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 23 payments from 8 companies in 2025. Trend: 2023 $1,287 · 2024 $5,107 · 2025 $831
Food & beverage: $654Education: $177
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 8 | $265 |
| Astellas Pharma US Inc | 3 | $210 |
| Adaptive Biotechnologies Corporation | 3 | $141 |
| Legend Biotech USA Inc. | 2 | $64 |
| Incyte Corporation | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $51 |
| PFIZER INC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: REZUROCK, clonoSEQ, CARVYKTI, Vanflyta, NIKTIMVO, Cresemba, JAKAFI, ELREXFIO.
Industry payments across FL — which companies pay providers there.
